Fortress Biotech Announces Receipt of Notice of Option Exercise from AstraZeneca to Fully Acquire Caelum Biosciences, a Company Founded by Fortress Biotech
Stock Information for Fortress Biotech Inc.
Loading
Please wait while we load your information from QuoteMedia.